Trial · NCT02932410
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=10 kg and <15 kg | 150.133 | Standard Deviation 67.5742 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=15 kg and <25 kg | 153.892 | Standard Deviation 108.3185 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=25 kg and <50 kg | 200.975 | Standard Deviation 151.6511 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=50 kg | 208.067 | Standard Deviation 92.4246 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=10 kg to <15 kg | 1165.000 | Standard Deviation 390.7628 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=15 kg and <25 kg | 859.333 | Standard Deviation 217.2926 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=25 kg and <50 kg | 980.857 | Standard Deviation 391.3308 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Body Weight | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=50 kg | 1011.267 | Standard Deviation 288.3632 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Age Group | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=2 to <6 years | 159.767 | Standard Deviation 84.5424 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Age Group | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=6 to <12 years | 184.792 | Standard Deviation 148.2530 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Age Group | Macitentan (JNJ-67896062) (>=2 Years) | Macitentan: >=12 to <18 years | 196.484 | Standard Deviation 88.1549 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Age Group | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=2 to <6 years | 1063.333 | Standard Deviation 376.4173 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Age Group | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=6 to <12 years | 957.211 | Standard Deviation 335.0858 | nanograms per milliliter (ng/mL) |
| Participants >=2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 Based on Age Group | Macitentan (JNJ-67896062) (>=2 Years) | Aprocitentan: >=12 to <18 years | 970.842 | Standard Deviation 298.5151 | nanograms per milliliter (ng/mL) |
| Participants <2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 4 | Macitentan (JNJ-67896062) (<2 Years) | Macitentan | 101.822 | Standard Deviation 91.9652 | ng/mL |
| Participants <2 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 4 | Macitentan (JNJ-67896062) (<2 Years) | Aprocitentan | 707.089 | Standard Deviation 465.5760 | ng/mL |
| Participants From China With >=12 to <18 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 | China Single-arm Cohort (>=12 to <18 Years) | Macitentan | 201.61 | Standard Deviation 116.685 | ng/mL |
| Participants From China With >=12 to <18 Years of Age: Observed Steady-State Trough (Pre-dose) Plasma Concentration of Macitentan and Aprocitentan (Active Metabolite) at Week 12 | China Single-arm Cohort (>=12 to <18 Years) | Aprocitentan | 1313.75 | Standard Deviation 293.644 | ng/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02932410/results